Business Context and Reporting Period
Company: DaVita HealthCare Partners Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 10, 2014
Event: Regulation FD Disclosure regarding the pricing of senior notes.
Key Financial Metrics
This filing reports a specific capital market transaction rather than periodic operating results.
- Debt Issuance: $1.75 Billion in Senior Notes.
- Revenue/Profit/Cash Flow: The filing text does not provide a clear value for these operating metrics.
- Liquidity: The issuance is intended to raise capital, though specific liquidity ratios are not disclosed in this text.
Material Changes
The primary material change is the expansion of the company's debt capital structure through the pricing of $1.75 billion in senior notes. No prior comparable period data is provided in this specific filing to calculate percentage changes in operating metrics.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release titled "DaVita HealthCare Partners Inc. Announces Pricing of $1.75 Billion Senior Notes" (Exhibit 99.1) for further details.
Legal Status: The information in this Form 8-K is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, limiting its incorporation by reference in other filings unless expressly stated.
Investor Verification Checklist
- Verify the interest rate, maturity date, and covenants of the $1.75 billion senior notes in the attached press release (Exhibit 99.1).
- Confirm the intended use of proceeds from the debt issuance.
- Review the company's most recent 10-Q or 10-K for current leverage ratios and liquidity positions to assess the impact of this new debt.
- Check for any underwriting agreements or lock-up periods associated with the note pricing.